Jonathan M Sorof
Overview
Explore the profile of Jonathan M Sorof including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
1091
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Trachtman H, Hainer J, Sugg J, Teng R, Sorof J, Radcliffe J
J Clin Hypertens (Greenwich)
. 2008 Dec;
10(10):743-50.
PMID: 19090875
This 4-week randomized, double blind, placebo-controlled study (N=240), 1-year open label trial (N=233), and single-dose pharmacokinetic study (N=22) evaluated candesartan cilexetil (3 doses) in hypertensive children aged 6 to 17...
2.
McNiece K, Gupta-Malhotra M, Samuels J, Bell C, Garcia K, Poffenbarger T, et al.
Hypertension
. 2007 Jun;
50(2):392-5.
PMID: 17592068
The National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents recently recommended staging hypertension (HTN) in children and adolescents based on blood pressure...
3.
McNiece K, Poffenbarger T, Turner J, Franco K, Sorof J, Portman R
J Pediatr
. 2007 May;
150(6):640-4, 644.e1.
PMID: 17517252
Objective: To determine the prevalence of hypertension and pre-hypertension on the basis of the 2004 National High Blood Pressure Education Program Working Group guidelines in an adolescent school-screening population. Study...
4.
Batisky D, Sorof J, Sugg J, Llewellyn M, Klibaner M, Hainer J, et al.
J Pediatr
. 2007 Jan;
150(2):134-9, 139.e1.
PMID: 17236889
Objective: To evaluate the efficacy, tolerability, and blood pressure (BP) lowering effect of extended release metoprolol succinate (ER metoprolol) in children 6 to 16 years of age with established hypertension....
5.
Vidt D, Harris S, McTaggart F, Ditmarsch M, Sager P, Sorof J
Am J Cardiol
. 2006 May;
97(11):1602-6.
PMID: 16728222
To define the effect of short-term rosuvastatin treatment on the estimated glomerular filtration rate (eGFR), the database of controlled clinical trials in the Rosuvastatin Clinical Development Program was reviewed. Thirteen...
6.
Samuels J, Franco K, Wan F, Sorof J
Pediatr Nephrol
. 2005 Oct;
21(1):92-5.
PMID: 16254730
Millions of children with attention deficit hyperactivity disorder (ADHD) are treated with stimulant medications. To evaluate cardiovascular risk, 24-h ambulatory blood pressure monitoring (ABPM) was performed on and off medication....
7.
Sorof J, Turner J, Franco K, Portman R
J Pediatr
. 2004 Apr;
144(4):485-9.
PMID: 15069397
Objectives: To determine whether there are clinical differences between children referred for hypertension evaluation from a primary care practice and children with hypertension detected through school-based screening. Study design Referral...
8.
Nesbitt S, Ashaye M, Stettler N, Sorof J, Goran M, Parekh R, et al.
Ethn Dis
. 2004 Mar;
14(1):94-110.
PMID: 15002929
The prevalence of overweight in youth is increasing dramatically in the United States. The intimate relationship of obesity and overweight with cardiovascular risk factors and diabetes in adults raises concern...
9.
Sorof J, Lai D, Turner J, Poffenbarger T, Portman R
Pediatrics
. 2004 Mar;
113(3 Pt 1):475-82.
PMID: 14993537
Objectives: To describe the current prevalence of pediatric hypertension and the relationships between gender, ethnicity, overweight, and blood pressure. Methods: School-based screening was performed in 5102 children (13.5 +/- 1.7...
10.
Sorof J, Turner J, Martin D, Garcia K, Garami Z, Alexandrov A, et al.
Hypertension
. 2004 Jan;
43(2):214-8.
PMID: 14744920
To determine whether systematic differences exist between hypertensive children referred for evaluation by primary care providers and children identified through community-based screening, cardiovascular risk factors and surrogate markers of hypertensive...